129 related articles for article (PubMed ID: 38460415)
21. Menopausal factors and risk of seropositive rheumatoid arthritis in postmenopausal women: a nationwide cohort study of 1.36 million women.
Eun Y; Jeon KH; Han K; Kim D; Kim H; Lee J; Lee DY; Yoo JE; Shin DW
Sci Rep; 2020 Nov; 10(1):20793. PubMed ID: 33247198
[TBL] [Abstract][Full Text] [Related]
22. Postmenopausal breast cancer risk and interactions between body mass index, menopausal hormone therapy use, and vitamin D supplementation: Evidence from the E3N cohort.
Cadeau C; Fournier A; Mesrine S; Clavel-Chapelon F; Fagherazzi G; Boutron-Ruault MC
Int J Cancer; 2016 Nov; 139(10):2193-200. PubMed ID: 27451078
[TBL] [Abstract][Full Text] [Related]
23. Inverse associations of dietary fiber and menopausal hormone therapy with colorectal cancer risk in the Multiethnic Cohort Study.
Park SY; Wilkens LR; Kolonel LN; Henderson BE; Le Marchand L
Int J Cancer; 2016 Sep; 139(6):1241-50. PubMed ID: 27137137
[TBL] [Abstract][Full Text] [Related]
24. Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort.
Wang SM; Pfeiffer RM; Gierach GL; Falk RT
Breast Cancer Res; 2020 Nov; 22(1):129. PubMed ID: 33239054
[TBL] [Abstract][Full Text] [Related]
25. Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study.
Cold S; Cold F; Jensen MB; Cronin-Fenton D; Christiansen P; Ejlertsen B
J Natl Cancer Inst; 2022 Oct; 114(10):1347-1354. PubMed ID: 35854422
[TBL] [Abstract][Full Text] [Related]
26. Association Between Menopausal Hormone Therapy and Risk for Parkinson's Disease.
Yuk JS; Jeong SH
J Parkinsons Dis; 2023; 13(8):1357-1367. PubMed ID: 37980684
[TBL] [Abstract][Full Text] [Related]
27. Effects of menopausal hormone therapy on the risk of ovarian cancer: Health Insurance Database in South Korea-based cohort study.
Yuk JS; Kim M
Menopause; 2023 May; 30(5):490-496. PubMed ID: 37022299
[TBL] [Abstract][Full Text] [Related]
28. Association between glycemic status and the risk of gastric cancer in pre/peri-and postmenopausal women: A nationwide cohort study.
Han KH; Choi YJ; Il Kim T; Park NH; Han KD; Lee DH
Ann Epidemiol; 2024 Jun; 94():106-112. PubMed ID: 38663524
[TBL] [Abstract][Full Text] [Related]
29. Is breast cancer risk the same for all progestogens?
Stute P
Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
[TBL] [Abstract][Full Text] [Related]
30. Menopausal hormone therapy may increase non-allergic rhinitis among postmenopausal women: Results from the Korea National Health and Nutrition Examination Survey (2010-2012).
Choi JH; Hwang SH; Suh JD; Kim JK; Hong SC; Lim YC; Kim SN; Cho JH
Maturitas; 2017 Aug; 102():46-49. PubMed ID: 28610682
[TBL] [Abstract][Full Text] [Related]
31. Reproductive factors and menopausal hormone therapy and bladder cancer risk in the NIH-AARP Diet and Health Study.
Daugherty SE; Lacey JV; Pfeiffer RM; Park Y; Hoover RN; Silverman DT
Int J Cancer; 2013 Jul; 133(2):462-72. PubMed ID: 23319449
[TBL] [Abstract][Full Text] [Related]
32. Menopause, hysterectomy, menopausal hormone therapy and cause-specific mortality: cohort study of UK Biobank participants.
Xu Z; Chung HF; Dobson AJ; Wilson LF; Hickey M; Mishra GD
Hum Reprod; 2022 Aug; 37(9):2175-2185. PubMed ID: 35690930
[TBL] [Abstract][Full Text] [Related]
33. Menopausal hormone therapy and risks of colorectal adenomas and cancers in the French E3N prospective cohort: true associations or bias?
Morois S; Fournier A; Clavel-Chapelon F; Mesrine S; Boutron-Ruault MC
Eur J Epidemiol; 2012 Jun; 27(6):439-52. PubMed ID: 22644109
[TBL] [Abstract][Full Text] [Related]
34. Interaction between current vitamin D supplementation and menopausal hormone therapy use on breast cancer risk: evidence from the E3N cohort.
Cadeau C; Fournier A; Mesrine S; Clavel-Chapelon F; Fagherazzi G; Boutron-Ruault MC
Am J Clin Nutr; 2015 Oct; 102(4):966-73. PubMed ID: 26354532
[TBL] [Abstract][Full Text] [Related]
35. Hormone therapy and Hypertension in Postmenopausal Women: Results from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
Ferreira-Campos L; Gabrielli L; Almeida MDCC; Aquino EML; Matos SMA; Griep RH; Aras R
Arq Bras Cardiol; 2022 May; 118(5):905-913. PubMed ID: 35613189
[TBL] [Abstract][Full Text] [Related]
36. Menopausal hormone therapy and risk of incident hypertension: role of the route of estrogen administration and progestogens in the E3N cohort.
Madika AL; MacDonald CJ; Fournier A; Mounier-Vehier C; Béraud G; Boutron-Ruault MC
Menopause; 2021 Sep; 28(11):1204-1208. PubMed ID: 34581294
[TBL] [Abstract][Full Text] [Related]
37. Breast Cancer Risk in Postmenopausal Women with Medical History of Thyroid Disorder in the Women's Health Initiative.
Weng CH; Okawa ER; Roberts MB; Park SK; Umbricht CB; Manson JE; Eaton CB
Thyroid; 2020 Apr; 30(4):519-530. PubMed ID: 31918623
[No Abstract] [Full Text] [Related]
38. Genetic risk impacts the association of menopausal hormone therapy with colorectal cancer risk.
Tian Y; Lin Y; Qu C; Arndt V; Baurley JW; Berndt SI; Bien SA; Bishop DT; Brenner H; Buchanan DD; Budiarto A; Campbell PT; Carreras-Torres R; Casey G; Chan AT; Chen R; Chen X; Conti DV; Díez-Obrero V; Dimou N; Drew DA; Figueiredo JC; Gallinger S; Giles GG; Gruber SB; Gunter MJ; Harlid S; Harrison TA; Hidaka A; Hoffmeister M; Huyghe JR; Jenkins MA; Jordahl KM; Joshi AD; Keku TO; Kawaguchi E; Kim AE; Kundaje A; Larsson SC; Marchand LL; Lewinger JP; Li L; Moreno V; Morrison J; Murphy N; Nan H; Nassir R; Newcomb PA; Obón-Santacana M; Ogino S; Ose J; Pardamean B; Pellatt AJ; Peoples AR; Platz EA; Potter JD; Prentice RL; Rennert G; Ruiz-Narvaez EA; Sakoda LC; Schoen RE; Shcherbina A; Stern MC; Su YR; Thibodeau SN; Thomas DC; Tsilidis KK; van Duijnhoven FJB; Van Guelpen B; Visvanathan K; White E; Wolk A; Woods MO; Wu AH; Peters U; Gauderman WJ; Hsu L; Chang-Claude J
Br J Cancer; 2024 Jun; 130(10):1687-1696. PubMed ID: 38561434
[TBL] [Abstract][Full Text] [Related]
39. Association between menopausal hormone therapy, mammographic density and breast cancer risk: results from the E3N cohort study.
Fornili M; Perduca V; Fournier A; Jérolon A; Boutron-Ruault MC; Maskarinec G; Severi G; Baglietto L
Breast Cancer Res; 2021 Apr; 23(1):47. PubMed ID: 33865453
[TBL] [Abstract][Full Text] [Related]
40. Menopausal hormone therapy and the risk of type 2 diabetes mellitus: Health Insurance Database in South Korea-based retrospective cohort study.
Yuk JS; Kim JM
Menopause; 2023 May; 30(5):497-505. PubMed ID: 36917757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]